A/Prof Grace Kong
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
104 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
Effect of [68Ga]Ga-PSMA-11 PET-CT in the diagnosis of prostate cancer in men with equivocal or clinically high-risk non-suspicious findings on multiparametric MRI (PRIMARY2): a multicentre, non-inferiority, phase 3, randomised controlled trial
DOI: 10.1016/S1470-2045(26)00120-82026
Journal article
Prognostic Value of Restaging [18F]FDG PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [177Lu]Lu-PSMA-617 Therapy.
DOI: 10.2967/jnumed.126.2725312026
Journal article
FAPI-CUP: A prospective cohort study of patients with cancer of unknown primary (CUP) to evaluate a novel radiotracer, fibroblast activated protein (FAPI), targeting cancer-associated fibroblasts for primary site detection.
DOI: 10.1200/jco.2026.44.16_suppl.30722026
Journal article
DISCO update: Diagnostic performance of 64 Cu-SARTATE compared to 68 Ga-DOTATATE in patients with known or suspected neuroendocrine tumors.
DOI: 10.1200/jco.2026.44.16_suppl.41742026
Journal article
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CT.
DOI: 10.2967/jnumed.125.2719952026
Journal article
THU-248 Hepatocellular carcinoma imaging using prostate-specific membrane antigen positron emission tomography - The Hepa-SMART trial
DOI: 10.1016/s0168-8278(26)01303-62017
Conference Proceedings
Lutetium-177 PSMA (LuPSMA) theranostics phase II trial: Efficacy, safety and QoL in patients with castrate-resistant prostate cancer treated with LuPSMA
DOI: 10.1093/annonc/mdx370.002
RECENT SCHOLARLY WORKS
2026
Journal article
[177Lu]Lu-PSMA-617 in combination with pembrolizumab for treatment of metastatic castration resistant prostate cancer (PRINCE): a single-arm, phase 1b/2 study
DOI: 10.1016/S1470-2045(26)00017-32026
Journal article
DISCO: Diagnostic performance of 64 Cu-SARTATE compared to 68 Ga-DOTATATE in patients with known or suspected neuroendocrine tumors with focus on liver findings.
DOI: 10.1200/jco.2026.44.2_suppl.6182025
Journal article
Prognostic Value of Initial Imaging and PSA Change with [177Lu]Lu-PSMA-617 Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A ProsTIC Registry Analysis
DOI: 10.2967/jnumed.125.2708042025
Journal article
Lutetium-177 [177Lu]Lu-PSMA-I&T plus radium-223 in patients with metastatic castration-resistant prostate cancer (AlphaBet): an interim analysis of the investigator-initiated, single-centre, single-arm, phase 1/2 trial
DOI: 10.1016/S1470-2045(25)00559-5